Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
About 60 to 70 Boulder police officers will be equipped with nasal atomizers to administer the drug, which reverses the effects of a heroin overdose
An uptick in bizarre calls involving patients who are often naked and delirious from flakka use puts responders in chaotic, dangerous situations
Just before the filming of a news segment, a WPXI photographer began CPR on a man he noticed slumped over in a vehicle
They were stabbed while assisting an ‘intoxicated’ man; the firefighters were listed in stable condition
The EMT told her boss in an internal investigation ‘I’m not about to be on no scene 10 minutes doing CPR’
The girl was stabilized at the pool before being taken to the hospital
EMS providers need to stop judging and take a more compassionate tact toward substance abuse users, hosts Chris Cebollero and Kelly Grayson say
Medics treated over 277 people in three weeks for medical emergencies related to synthetic marijuana
It’s time for EMS clinical leaders to discuss the role of targeted antibiotics which are safe and effective when administered to the right patients
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.